Topics

Latest "MAP To Provide Access To Crizanlizumab, For Sickle Cell Disease Patients" News Stories

23:06 EDT 28th March 2020 | BioPortfolio

Here are the most relevant search results for "MAP To Provide Access To Crizanlizumab, For Sickle Cell Disease Patients" found in our extensive news archives from over 250 global news sources.

More Information about MAP To Provide Access To Crizanlizumab, For Sickle Cell Disease Patients on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MAP To Provide Access To Crizanlizumab, For Sickle Cell Disease Patients for you to read. Along with our medical data and news we also list MAP To Provide Access To Crizanlizumab, For Sickle Cell Disease Patients Clinical Trials, which are updated daily. BioPortfolio also has a large database of MAP To Provide Access To Crizanlizumab, For Sickle Cell Disease Patients Companies for you to search.

Showing "Provide Access Crizanlizumab Sickle Cell Disease Patients" News Articles 1–25 of 46,000+

Saturday 28th March 2020

CDC warns residents of New York, New Jersey, Connecticut against non-essential travel

The Centers for Disease Control and Prevention on Saturday warned residents of New York, New Jersey, and Connecticut against non-essential domestic travel for 14 days.


South Korea reports 105 new coronavirus cases, total now at 9,583: KCDC

South Korea had confirmed 105 new coronavirus cases as of midnight Saturday, bringing the country's total now to 9,583, the Korea Centers for Disease Control and Prevention said on Sunday.

As more companies gear up to fight the spread of the novel coronavirus, a growing number of government officials, lawmakers, academics, and advocacy groups are seeking to ensure widespread access to medical products for combating Covid-19. https://buff.ly

As more companies gear up to fight the spread of the novel coronavirus, a growing number of government officials, lawmakers, academics, and advocacy groups are seeking to ensure widespread access to medical products for combating Covid-19. https://buff.ly/2ybHn6V 


United Bank For Africa (UBA) Announces it Will Provide $14 million USD (N5 billion) To COVID-19 Relief Support Across Africa

United Bank For Africa (UBA) Joins the Ranks of Financial Institutions Providing Millions in COVID-19's Economic Relief NEW YORK (PRWEB) March 28, 2020 MARCH 28, 2020 – United Bank for Africa Plc (UBA) announced a donation of $14 million USD (5 billion Naira), through the UBA Foundation, to catalyze a comprehensive pan-African response to the fight against the coronavirus (COVID-19) global ...

Airbnb hosts to provide free rooms for British health workers

Airbnb hosts will provide free rooms for workers in Britain's National Health Service (NHS) to support their work during the coronavirus outbreak, the company said on Sunday.

CAR T-Cell Approach Brought to Once-Resistant Macrophages: http://ow.ly/MeJ850yVlDQ pic.twitter.com/dJWv8jbP6T

CAR T-Cell Approach Brought to Once-Resistant Macrophages: http://ow.ly/MeJ850yVlDQ  pic.twitter.com/dJWv8jbP6T

AHF Mourns Passing of Former Senator Tom Coburn (R-OK)

Global nonprofit AIDS care provider salutes former senator as leader in Congress pushing for global access to HIV/AIDS care and treatment. AIDS Healthcare Foundation (AHF) mourns the death earlier today of former United State Senator Tom Coburn (R-OK). According to CNN, Coburn “…died at his home Saturday, according to a statement from his family. He was 72.”

Rivaroxaban Plus Aspirin Safely Benefits PAD Patients

Results of VOYAGER-PAD show a combined regimen of rivaroxaban and aspirin was safe and reduced ischemic events in peripheral arterial disease patients after lower limb revascularization. Medscape Medical News

IsoPlexis, @isbsci Partner on #COVID19 Single-Cell Functional Immune Response Mapping: http://ow.ly/OGs750yVkaD pic.twitter.com/jSc6oNNn0o

IsoPlexis, @isbsci Partner on #COVID19 Single-Cell Functional Immune Response Mapping: http://ow.ly/OGs750yVkaD  pic.twitter.com/jSc6oNNn0o

Bloom Energy, State of California, Almo Partner to Refurbish Ventilators for Healthcare System as COVID-19 Spreads Throughout U.S.

Companies leverage expertise to breathe new life into machines in fight against coronavirus Bloom Energy Corp. (NYSE: BE) and Almo Corporation today announced they are joining forces to refurbish unused, out-of-warranty ventilators and ship them to state agencies and hospitals throughout the country, particularly as an increasing number of patients experience critical respiratory issues as a res...

VICTORIA: Vericiguat Seen as Novel Success in High-Risk HFrEF

The relative risk reduction was modest, but experts say the benefit in absolute terms was remarkable for already well-treated patients, who are some of the hardest to keep out of the hospital. Medscape Medical News

A #Microbiome Search Engine for Disease Diagnostics: http://ow.ly/avwf50yUd4J pic.twitter.com/4RF0DIvMUe

A #Microbiome Search Engine for Disease Diagnostics: http://ow.ly/avwf50yUd4J  pic.twitter.com/4RF0DIvMUe

Coronary Heart Disease Risk Reduced by Eating Tofu and Foods Containing Isoflavones: http://ow.ly/TAtz50yUd0M pic.twitter.com/W5APNFcyyd

Coronary Heart Disease Risk Reduced by Eating Tofu and Foods Containing Isoflavones: http://ow.ly/TAtz50yUd0M  pic.twitter.com/W5APNFcyyd

CORRECTING and REPLACING Stratasys Coalition for Face Shield Production With 3D Printing Now Numbers Over 150 Organizations Responding to Pandemic

Requests from hospitals and other organizations exceed 350,000 shields; first hospital shipment received on Mar. 25 First paragraph, second sentence of release dated March 27, 2020 should include General Atomics sted Toyota Motor Company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200327005345/en/

STAT Plus: New drug from Merck, Bayer reduces hospitalizations for heart failure patients

An experimental drug from Merck and Bayer cut hospitalizations for heart failure by 10% in a new study.

There is "a toxic, suspicious, paranoid, dog-eat-dog culture that emerges during an outbreak" @PardisSabeti speaking on #FirstRounders podcast in Oct 2019 about infectious disease outbreaks. Worth a listen today. @NatureBiotech http://aca.st/b36c6c 

There is "a toxic, suspicious, paranoid, dog-eat-dog culture that emerges during an outbreak" @PardisSabeti speaking on #FirstRounders podcast in Oct 2019 about infectious disease outbreaks. Worth a listen today. @NatureBiotech http://aca.st/b36c6c 

FDA OKs Emergency Use of Convalescent Plasma for COVID-19 Patients

As the number of US patients infected with COVID-19 continues to rise, the FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or life-threatening infections. Medscape Medical News

I am a physician, and I am scared

I am a physician, and I am scared. I am scared for my patients, my friends, my family, and most of all, I am scared for my colleagues. As an oncologist, I am not someone yet on the frontlines treating patients acutely diagnosed with COVID-19, although when the call for all hands-on deck comes, I […] Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs n...

Researchers Rush To Create Self-Sanitizing Face Masks To Reduce Spread Of Coronavirus

Researchers in Illinois are rushing to create an anti-viral sticker to be used on face masks worn by patients with COVID-19.

GEN Edge -- @cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies: http://ow.ly/CAqN50yRp80 pic.twitter.com/xS70pUb2Bu

GEN Edge -- @cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies: http://ow.ly/CAqN50yRp80  pic.twitter.com/xS70pUb2Bu

UAE extends nightly curfew, Qatar reports first coronavirus death

The United Arab Emirates extended on Saturday to April 5 a nightly curfew to sterilise public places to combat the coronavirus as neighbouring Qatar reported its first death from the disease.

Mental Health Effects of COVID-19 on Healthcare Workers in China

The effects were greatest in nurses, women, those directly caring for virus patients, and those working at the epicenter in Wuhan.

Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death, Compared to Placebo, When Given in Combination with Available Heart Failure Therapies

Phase 3 VICTORIA Trial is the First Contemporary Outcomes Study Focused Exclusively on a Chronic Heart Failure Patient Population Following a Worsening Event Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally ...

FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial

New data showed consistent effect of FARXIGA in patients with heart failure with reduced ejection fraction, regardless of background therapy New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showed that AstraZeneca’s FARXIGA (dapagliflozin) reduced the incidence of the primary composite endpoint of heart fa...

Live Notes from Town Hall for Patients with Leading Oncologists on Lung Cancer and COVID19 3_28_20

Live Notes from Town Hall for Patients with Leading Oncologists on Lung Cancer and COVID19 3_28_20 Reporter: Stephen J. Williams, PhD Leading Lung Cancer Oncologists from around the world are meeting and discussing concerns for lung cancer patients and oncologist during the novel coronavirus (SARS-COV2; COVID19) pandemic.  The town hall “COVID-19 and the Impact on […]


Quick Search

News Quicklinks